ArticleJournal of nanobiotechnology2018

In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis.

Aristides D Tagalakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.